Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Simponi price, strengths & recalls

Brand of golimumab (generic)

Pharmacies pay $6,450.56 for 0.5 mL of Simponi 100 mg/mL, 0.5 mL auto-injector this week, and from $6,450.56 to $6,488.62 across its 2 priced strengths and forms. Its official label last changed on November 4, 2026.

Brand
Pharmacies pay$6,450.56for 0.5 mL of 100 mg/mL, 0.5 mL auto-injector+0.1% in 4 weeks
Fair cash price
$7,428.64
Strengths
2
Makers
1
Updated
Nov 11

Simponi price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
100 mg/mL, 0.5 mL auto-injector Brand$12,901.13$6,450.56 / 0.5 mL+0.1%+4.4%
100 mg/mL, 1 mL auto-injector BrandNot priced this week
100 mg/mL, 0.5 mL prefilled syringe Brand$12,977.24$6,488.62 / 0.5 mLNo change+5.0%

Simponi vs generic golimumab

There is no generic version of Simponi on the market yet.

GenericGolimumab prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 15, 2026
No ongoing recallsNone on record

What did you pay for simponi? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedNovember 4, 2026
Version44 of 41
EffectiveNov 2, 2026
Read the label

These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI ®(golimumab) injection, for subcutaneous use Initial U.S. Approval: 2009

This drug has a boxed warning

WARNING: SERIOUS INFECTIONS AND MALIGNANCY

WARNING: SERIOUS INFECTIONS AND MALIGNANCY

See full prescribing information for complete boxed warning.

Serious infections leading to hospitalization or death including tuberculosis (TB), bacterial sepsis, invasive fungal (such as histoplasmosis), and other opportunistic infections have occurred in patients receiving SIMPONI (

5.1)

Discontinue SIMPONI if a patient develops a serious infection or sepsis (

5.1)

Perform test for latent TB; if positive, start treatment for TB prior to starting SIMPONI (

5.1)

Monitor all patients for active TB during treatment, even if initial latent TB test is negative (

5.1)

Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, of which SIMPONI is a member (

5.2)

SERIOUS INFECTIONS

Patients treated with SIMPONI are at increased risk for developing serious infections that may lead to hospitalization or death

[see

Warnings and Precautions (5.1)]

. Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids.

Discontinue SIMPONI if a patient develops a serious infection.

Reported infections with TNF blockers, of which SIMPONI is a member, include:

Active tuberculosis, including reactivation of latent tuberculosis. Patients with tuberculosis have frequently presented with disseminated or extrapulmonary disease. Test patients for latent tuberculosis before SIMPONI use and during therapy. Initiate treatment for latent TB prior to SIMPONI use.

Invasive fungal infections including histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients with histoplasmosis or other invasive fungal infections may present with disseminated, rather than localized, disease. Antigen and antibody testing for histoplasmosis may be negative in some patients with active infection. Consider empiric antifungal therapy in patients at risk for invasive fungal infections who develop severe systemic illness.

Bacterial, viral, and other infections due to opportunistic pathogens, including Legionella and Listeria.

Consider the risks and benefits of treatment with SIMPONI prior to initiating therapy in patients with chronic or recurrent infection.

Monitor patients closely for the development of signs and symptoms of infection during and after treatment with SIMPONI, including the possible development of tuberculosis in patients who tested negative for latent tuberculosis infection prior to initiating therapy

[see

Warnings and Precautions (5.1)]

.

MALIGNANCY

Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, of which SIMPONI is a member[seeWarnings and Precautions (5.2)]

.

Recent major changes (as listed on the label)

Indications and Usage (1.4) | 10/2025 |

Dosage and Administration (2.1, 2.3, 2.4) | 10/2025 |

Warnings and Precautions (5.11) | 10/2025 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
BLA125289 · Centocor Ortho Biotech Inc
First approved
April 24, 2009 (17 years ago)
Latest approved change
October 22, 2025
Approved label
PDF, Oct 23, 2025
Generic makers
None on the market

Simponi questions

How much does simponi cost without insurance?

Pharmacies pay about $6,450.56 for 0.5 mL of simponi 100 mg/mL, 0.5 mL auto-injector ($12,901.13 per mL). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $7,428.64. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Simponi?

Yes: golimumab. Compare golimumab prices.

Is simponi in shortage?

No shortage is reported for simponi right now. We check the national shortage list every day.

Has simponi been recalled?

No recalls are on record for simponi.

When did the simponi label last change?

The official label was last updated on November 4, 2026 (version 44). See what changed.

Talk about simponi

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.